The co is making progress on trials as they have mentioned in the past - that is good news.
Let’s see if they made any better revenues? If the revenues from the 4 products (basically scrap ones) cover the additional marketing, selling and employee costs then they are worth it.
If they can file for at least one NDA in Q1-2019, it is good progress. They we can see price above $10.